Bellevue Asset Management (Switzerland)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
BFA
BB
BIT
Bellevue Asset Management (Switzerland)'s NVAX Position: Q4 2015 in Review
Bellevue Asset Management (Switzerland) held its Novavax (NVAX) position steady in Q4 2015 at 16,250 shares worth $2.73M. The position accounts for 0.42% of the portfolio, ranked #72.
Bellevue Asset Management (Switzerland) first reported a position in NVAX in Q1 2015 and has held it in 4 quarters since. The position peaked at $5.79M in Q2 2015. 173 funds tracked by Wall St. Rank hold NVAX as of Q4 2015.
- Bellevue Asset Management (Switzerland) held 16,250 shares of Novavax worth $2.73M as of Q4 2015.
- Bellevue Asset Management (Switzerland) left its Novavax share count unchanged in Q4 2015.
- Novavax made up 0.42% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #72 holding.
- Bellevue Asset Management (Switzerland) first reported a position in Novavax in Q1 2015 and has held it in 4 quarters since.
- Bellevue Asset Management (Switzerland)'s Novavax position peaked at $5.79M in Q2 2015.
- 173 funds tracked by Wall St. Rank held Novavax as of Q4 2015.
Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.